Clinical Update Forty-Six: Recently Approved in Europe

Recently Approved in Europe — Lower Anticoagulation Maintenance of Aortic Heart Valve Recipients!1 Introducing the On-X® Plus 1.5™ Aortic Heart Valve: Significantly reduced bleeding for On-X aortic heart valve patients does not increase the stroke rate.2   European aortic valve patients can now take less warfarin for lowered bleeding rates The On-X valve is the […]

Clinical Update Forty-Five: Tissue Valve Failure

Factors leading to premature tissue valve failure Accelerated failure of biological valve replacements due to diabetes, atherosclerosis, metabolic syndrome, hypercholesterolemia and patient-prosthesis mismatch puts patients at risk.1-5   Recently published studies describe a variety of conditions common in patients with heart valve disease that can cause early tissue valve failure. Diabetes is a 3X higher […]

Clinical Update Forty-Four: Valve Choice

Valve Choice Has Long-Term Complication and Cost Implications for Patients and Healthcare Providers Comparative long-term cost model shows choosing the On-X heart valve for implantation in young patients could save: $59,000 over choosing a stented tissue (ST) valve with ST at re-op1, $376,000 over choosing a stented tissue (ST) valve with TAVI/ ViV at re-op1 […]

Clinical Update Forty-Three: Reduction of Air Emboli

Successful reduction of air emboli during open heart procedures The CarbonAid® and CarbonMiniTM CO2 diffusion catheters protect patients by minimizing air emboli, by increasing bacteriostasis and by repelling particulate contamination during surgery.   The CarbonAid Carbon Dioxide (CO2) Diffuser is clearly a beneficial adjunct to open heart surgery–any time the heart is opened, especially for […]

Clinical Update Forty-Two: Mitral Valve

Optimal flow in a mitral valve Less mismatch with the On-X mitral valve proves that optimal flow is achieved at a smaller nominal size.1  

Clinical Update Forty-One: On-X Heart Valve

The On-X Heart Valve at 12 years Long term follow-up of the On-X valve confirms its early performance of clinical excellence.1,2   European data establishes the On-X valve as market leader A three center retrospective study of 691 patients from 1998 through 2009 inclusivley produced low complication rates.1 John Chambers of Guy’s and St. Thomas […]

Clinical Update Thirty-Nine: Tissue Valve Failure

Factors leading to premature tissue valve failure Accelerated failure of biological valve replacements due to diabetes, atherosclerosis, metabolic syndrome, hypercholesterolemia and patient-prosthesis mismatch puts patients at risk.1-5   Recently published studies describe a variety of conditions common in patients with heart valve disease that can cause early tissue valve failure. Diabetes is a 3X higher […]

Clinical Update Thirty-Eight: Improved Mortality

Improved mortality for mechanical valve patients Several recent clinical trials provide evidence of superior durability, reoperation rates and mortality for mechanical valve recipients compared to biological valve recipients.1-9   Matched study results favor mechanical valves In an abstract presented earlier this year at the Society of Thoracic Surgery, Weber, et al., of Switzerland offered the […]

Clinical Update Thirty-Six: Anticoagulant Drugs

The Ignored Benefits of Anticoagulant Drugs In an aging population, anticoagulant drugs provide benefits that are often ignored in favor of repeated valve operations.   Benefits of Warfarin Current heart valve selection criteria is heavily weighted toward tissue valve implants even when an increasing number of randomized or matched clinical studies show the risks of […]

Clinical Update Thirty-Five: Lowered Anticoagulation

Lowered Anticoagulation Trial Preliminary Results The On-X® Prosthetic Heart Valve continues to demonstrate tolerance of low INR that has been seen in worldwide studies.   A unique study of On-X heart valves The Prospective Randomized On-X Valve Anticoagulation Trial (PROACT) was initiated in 2006 and is currently ongoing in 36 centers throughout the United States […]

Onxlti Responsive Menu
Menu